于2023年购股权计划期间及直至本公告日期，公司已于2023年6月16日授出合共6738万份购股权。考虑到根据2023年购股权计划注销上述3367万份购股权及失效的3371万份购股权，2023年购股权计划项下并无购股权已获行使，亦无购股权尚未行使。Hopefluent (00733) announced that, in accordance with the terms of the 2023 stock option plan approved by the board of directors (including...
According to the announcement by Hopefluent (00733), under the terms of the 2023 stock option plan approved by the board of directors (including approval by independent non-executive directors), a total of 33.67 million unexercised stock options granted to a director and several employees of the company are cancelled, effective from November 1, 2024.
Under the 2023 stock option plan, the maximum number of shares that can be granted under the 2023 stock option plan shall not exceed 10% of the total number of issued shares as of the adoption date on May 23, 2023 (i.e., a total of 67.415 million shares).
During the 2023 stock option plan period and up to the date of this announcement, the company had granted a total of 67.38 million stock options as of June 16, 2023. Taking into account the cancellation of the above 33.67 million stock options and the expiration of 33.71 million stock options under the 2023 stock option plan, no stock options have been exercised under the 2023 stock option plan, and there are also no stock options remaining unexercised.
As of the date of this announcement, the company has no specific plans or intentions to grant any stock options under the 2023 stock option plan after the date of this announcement and up to the date of the extraordinary general meeting of shareholders. However, the board of directors does not rule out the possibility that the company may grant stock options under the 2023 stock option plan in the future as needed to incentivize eligible participants selected. The company will make further announcements in due course in accordance with the listing rules.
